These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 31903161)

  • 1. Monoclonal antibody-based molecular imaging strategies and theranostic opportunities.
    Dammes N; Peer D
    Theranostics; 2020; 10(2):938-955. PubMed ID: 31903161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal Antibodies: A Review.
    Singh S; Kumar NK; Dwiwedi P; Charan J; Kaur R; Sidhu P; Chugh VK
    Curr Clin Pharmacol; 2018; 13(2):85-99. PubMed ID: 28799485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theranostics and metabolotheranostics for precision medicine in oncology.
    Bhujwalla ZM; Kakkad S; Chen Z; Jin J; Hapuarachchige S; Artemov D; Penet MF
    J Magn Reson; 2018 Jun; 291():141-151. PubMed ID: 29705040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theranostics Using Antibodies and Antibody-Related Therapeutics.
    Moek KL; Giesen D; Kok IC; de Groot DJA; Jalving M; Fehrmann RSN; Lub-de Hooge MN; Brouwers AH; de Vries EGE
    J Nucl Med; 2017 Sep; 58(Suppl 2):83S-90S. PubMed ID: 28864618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular imaging in nuclear cardiology: Pathways to individual precision medicine.
    Glasenapp A; Hess A; Thackeray JT
    J Nucl Cardiol; 2020 Dec; 27(6):2195-2201. PubMed ID: 32893320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Less Exploited GPCRs in Precision Medicine: Targets for Molecular Imaging and Theranostics.
    Franco Machado J; Silva RD; Melo R; G Correia JD
    Molecules; 2018 Dec; 24(1):. PubMed ID: 30583594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging in drug development: Update and challenges for radiolabeled antibodies and nanotechnology.
    Colombo I; Overchuk M; Chen J; Reilly RM; Zheng G; Lheureux S
    Methods; 2017 Nov; 130():23-35. PubMed ID: 28743635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy and the role of imaging.
    Carter BW; Bhosale PR; Yang WT
    Cancer; 2018 Jul; 124(14):2906-2922. PubMed ID: 29671876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody based radiopharmaceuticals for imaging and therapy.
    Lin M; Paolillo V; Le DB; Macapinlac H; Ravizzini GC
    Curr Probl Cancer; 2021 Oct; 45(5):100796. PubMed ID: 34657748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody therapeutics and immunoregulation in cancer and autoimmune disease.
    Yasunaga M
    Semin Cancer Biol; 2020 Aug; 64():1-12. PubMed ID: 31181267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Checkpoint Imaging in Oncology: A Game Changer Toward Personalized Immunotherapy?
    Lütje S; Feldmann G; Essler M; Brossart P; Bundschuh RA
    J Nucl Med; 2020 Aug; 61(8):1137-1144. PubMed ID: 31924724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the complexity of therapeutic drug monitoring for monoclonal antibody therapies to individualize dose in oncology.
    Chatelut E; Hendrikx JJMA; Martin J; Ciccolini J; Moes DJAR
    Pharmacol Res Perspect; 2021 Apr; 9(2):e00757. PubMed ID: 33745217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monoclonal antibody therapy].
    Pitzalis C; Pipitone N; Marcolongo R; Galeazzi M
    Recenti Prog Med; 1997 Mar; 88(3):128-33. PubMed ID: 9173470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized & Precision Medicine in Cancer: A Theranostic Approach.
    Choudhury P; Gupta M
    Curr Radiopharm; 2017 Nov; 10(3):166-170. PubMed ID: 28758574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal Antibodies: What the Diagnostic Neuroradiologist Needs to Know.
    Alsufayan R; Hess C; Krings T
    AJNR Am J Neuroradiol; 2023 Dec; 44(12):1358-1366. PubMed ID: 37591772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pros and cons of the immunogenicity of monoclonal antibodies in cancer treatment: a lesson from autoimmune diseases.
    Talotta R; Rucci F; Canti G; Scaglione F
    Immunotherapy; 2019 Feb; 11(3):241-254. PubMed ID: 30730275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the development of nanoparticles for multimodality imaging and therapy of cancer.
    Liu M; Anderson RC; Lan X; Conti PS; Chen K
    Med Res Rev; 2020 May; 40(3):909-930. PubMed ID: 31650619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized Immuno-Oncology.
    Jain KK
    Med Princ Pract; 2021; 30(1):1-16. PubMed ID: 32841942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future perspectives of therapeutic monoclonal antibodies.
    Tsumoto K; Isozaki Y; Yagami H; Tomita M
    Immunotherapy; 2019 Feb; 11(2):119-127. PubMed ID: 30730271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Radiolabeled Monoclonal Antibodies in Cancer Imaging and ADC Treatment.
    Martiniova L; Zielinski RJ; Lin M; DePalatis L; Ravizzini GC
    Cancer J; 2022 Nov-Dec 01; 28(6):446-453. PubMed ID: 36383907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.